Cancer Screening and Prevention

Cancer screening and prevention

Current Projects

Acupressure for Persistent Cancer Related Fatigue

Suzanna M. Zick, N.D., M.P.H., Principal Investigator
Ananda Sen, Ph.D., Co-Investigator

Funded by the National Institutes of Health, The National Cancer Institute

This randomized, single-blind, placebo controlled study will examine the effect of two different acupressure treatments compared to standard of care, since self-administered acupressure has been demonstrated to decrease persistent cancer-related fatigue (PCRF) for breast cancer survivor

Modeling Professional Attitudes and Teaching Humanistic Communication in Virtual Reality (MPathic VR)

Michael D. Fetters, M.D., M.P.H., M.A., Principal Investigator

Funded by The National Institutes of Health

The M-Pathic VR II project will rigorously evaluate the extent that the newly successful "virtual reality" software program (developed in Phase I) can enhance medical school curricula in professionalism, empathy, and in patient-centeredness (using verbal and non-verbal communication skills) as well as the ACGME competencies when treating a terminally ill cancer patient.

Multi-Level Approaches to Screening for Colorectal and Cervical Cancers in Rural Primary Care Settings

Sherri Sheinfeld Gorin, Ph.D., FSBM., PI | sherri.gorin@gmail.com and ssgorin@med.umich.edu

Masahito Jimbo, M.D., Ph.D., M.P.H., Co-PI | mjimbo@med.umich.edu

Funded by the Michigan Institute for Clinical & Health Research 

The goal of the MICHR Accelerating Synergy Positioning Project (called the Primary Care Rural Screening Project ,PCRSP) is to advance understanding of the multi-level healthcare policy, institution, physician, provider team, and patient factors that contribute to colorectal, cervical, and lung cancer-related health disparities in incidence and mortality among rural populations, and the implications of these inequities.

Translational Research in GI Cancer

Ananda Sen, Ph.D., Co-Investigator
Zora Djuric, Ph.D., Co-Investigator

Funded by the National Institutes of Health

The Specialized Program of Research Excellence will address the hypothesis that identifying and developing interventions to address molecular events that enhance cellular carcinogenesis or cellular transformed phenotype will reduce the morbidity and mortality associated with colorectal and pancreatic cancers through risk identification, preventive interventions, early detection, or improved treatment of invasive cancer.